Answers are grounded in this paper and cite their sources.
All authors have been or are involved in clinical trials with angiotensin receptor blockers in cardiovascular disease and have received honorariums for speaking, consultancy fees, and research
No takes yet. Share an insight, caveat, or question.
John J.V. McMurray (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: